Kangmei Pharmaceutical Statistics

Total Valuation

Kangmei Pharmaceutical has a market cap or net worth of CNY 24.40 billion. The enterprise value is 23.88 billion.

Market Cap	24.40B
Enterprise Value	23.88B

Important Dates

The next estimated earnings date is Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Kangmei Pharmaceutical has 13.86 billion shares outstanding. The number of shares has decreased by -21.29% in one year.

Shares Outstanding	13.86B
Shares Change (YoY)	-21.29%
Shares Change (QoQ)	+221.89%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	12.92%
Float	9.74B

Valuation Ratios

The trailing PE ratio is 80.31.

PE Ratio	80.31
Forward PE	n/a
PS Ratio	3.94
PB Ratio	3.45
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.00, with an EV/FCF ratio of -44.74.

EV / Earnings	97.80
EV / Sales	4.80
EV / EBITDA	37.00
EV / EBIT	76.90
EV / FCF	-44.74

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 3.33.

Current Ratio	1.49
Quick Ratio	0.84
Debt / Equity	3.33
Debt / EBITDA	0.37
Debt / FCF	-0.44
Interest Coverage	5.55

Financial Efficiency

Return on equity (ROE) is 3.54% and return on invested capital (ROIC) is 2.69%.

Return on Equity (ROE)	3.54%
Return on Assets (ROA)	1.35%
Return on Capital (ROIC)	2.69%
Revenue Per Employee	1.13M
Profits Per Employee	55,373
Employee Count	4,409
Asset Turnover	0.34
Inventory Turnover	1.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.38% in the last 52 weeks. The beta is 0.58, so Kangmei Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-6.38%
50-Day Moving Average	1.90
200-Day Moving Average	1.91
Relative Strength Index (RSI)	35.72
Average Volume (20 Days)	73,879,238

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kangmei Pharmaceutical had revenue of CNY 4.97 billion and earned 244.14 million in profits. Earnings per share was 0.02.

Revenue	4.97B
Gross Profit	655.95M
Operating Income	310.49M
Pretax Income	250.65M
Net Income	244.14M
EBITDA	590.24M
EBIT	310.49M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 795.04 million in cash and 236.15 million in debt, giving a net cash position of 558.89 million or 0.04 per share.

Cash & Cash Equivalents	795.04M
Total Debt	236.15M
Net Cash	558.89M
Net Cash Per Share	0.04
Equity (Book Value)	7.10B
Book Value Per Share	0.51
Working Capital	2.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -446.20 million and capital expenditures -87.46 million, giving a free cash flow of -533.66 million.

Operating Cash Flow	-446.20M
Capital Expenditures	-87.46M
Free Cash Flow	-533.66M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 13.19%, with operating and profit margins of 6.25% and 4.91%.

Gross Margin	13.19%
Operating Margin	6.25%
Pretax Margin	5.04%
Profit Margin	4.91%
EBITDA Margin	11.87%
EBIT Margin	6.25%
FCF Margin	-10.73%

Dividends & Yields

Kangmei Pharmaceutical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	21.29%
Shareholder Yield	21.29%
Earnings Yield	1.25%
FCF Yield	-2.19%

Stock Splits

The last stock split was on June 16, 2015. It was a forward split with a ratio of 2.

Last Split Date	Jun 16, 2015
Split Type	Forward
Split Ratio	2